copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
WHO Drug Information About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
Drugs (psychoactive) - World Health Organization (WHO) The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important
Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours
WHO updates guidelines on opioid dependence treatment and overdose . . . WHO announces development of updated guidelines for the psychosocially assisted pharmacological treatment of opioid dependence and community management of opioid overdoseIn 2022, approximately 60 million people globally engaged in non-medical opioid use, including the use of drugs like heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances Their regular non
Seventy-eighth World Health Assembly – Daily update: 23 May 2025 The World Health Organization (WHO) has released a rapid communication outlining its new guideline on balanced national policies for controlled medicines The guideline was officially presented during a high-level side event at the Seventy-eighth World Health Assembly It is designed to support countries in ensuring safe, equitable and affordable access to essential controlled medicines which
Global status report on alcohol and health and treatment of substance . . . The Global status report on alcohol and health and treatment of substance use disorders presents a comprehensive overview of alcohol consumption, alcohol-related harm and policy responses as well as treatment capacities for alcohol and drug use disorders worldwide The report is based on data collected by WHO from Member States and organized in accordance with the Sustainable Development Goals
WHO announces landmark changes in treatment of drug-resistant tuberculosis The World Health Organization (WHO) today released its Consolidated guidelines on tuberculosis (TB)- Module 4: treatment and care, consolidating all previous guidelines into a single comprehensive document and introducing significant improvements in treatment options for people with multidrug-resistant or rifampicin-resistant tuberculosis (MDR RR-TB)
Strategies - World Health Organization (WHO) Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem It is an essential component of patient care and rational use of medicines It is also variously referred to as adverse drug reaction monitoring, drug safety surveillance, side effect monitoring, spontaneous reporting, post
UN Commission approves WHO recommendations to place psychoactive . . . Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under international control